Showing results (4651-4660 of 5,702) with videos related to
Sort By:
Pageof 571
The Oncologist|December 2, 2016
Randomized Phase II Study of Cabazitaxel Versus Methotrexate in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Previously Treated With Platinum-Based TherapyJean-Pascal Machiels, Aline Van Maanen, Jean-Marie Vandenbulcke, et al.The Oncologist|May 6, 2014
Measures of outcome in metastatic breast cancer: insights from a real-world scenarioMarta Bonotto, Lorenzo Gerratana, Elena Poletto, et al.The Oncologist|October 30, 2016
A Phase I Study of the Safety and Pharmacokinetics of Higher-Dose Icotinib in Patients With Advanced Non-Small Cell Lung CancerJian Liu, Lihua Wu, Guolan Wu, et al.The Oncologist|February 10, 2017
Key Lessons Learned from Moffitt's Molecular Tumor Board: The Clinical Genomics Action Committee ExperienceTodd C Knepper, Gillian C Bell, J Kevin Hicks, et al.The Oncologist|February 16, 2017
A Phase I/IIa Study of DHP107, a Novel Oral Paclitaxel Formulation, in Patients with Advanced Solid Tumors or Gastric CancerMin-Hee Ryu, Baek-Yeol Ryoo, Tae Won Kim, et al.The Oncologist|September 30, 2016
Broad Detection of Alterations Predicted to Confer Lack of Benefit From EGFR Antibodies or Sensitivity to Targeted Therapy in Advanced Colorectal CancerAndrew Rankin, Samuel J Klempner, Rachel Erlich, et al.The Oncologist|May 30, 2003
The forgotten myeloproliferative disorder: myeloid metaplasiaAyalew TefferiThe Oncologist|May 30, 2003
Chemotherapy options for the elderly patient with advanced non-small cell lung cancerB T Hennessy, E O Hanrahan, O S BreathnachThe Oncologist|May 30, 2003
Advances in the diagnosis and treatment of neuroblastomaJoanna L Weinstein, Howard M Katzenstein, Susan L CohnThe Oncologist|October 8, 2003
Pros and cons of adjuvant interferon in the treatment of melanomaMichael S Sabel, Vernon K SondakPageof 571